Skip to main content
. 2020 Jun 30;18:262. doi: 10.1186/s12967-020-02440-7

Table 2.

Echocardiographic and hemodynamic parameters measured at euthanasia day (mean ± SD)

Parameter I—non-PAH control II—early PAH III—end-stage PAH IV—end-stage PAH with myocarditis p-value
ANOVA or Kruskal–Wallis test
Pairwise comparisons
p-value
I vs. II
p-value
I vs. III
p-value
I vs. IV
p-value
II vs. III
p-value
II vs. IV
p-value
III vs. IV
LVFWTd (mm) 0.20 ± 0.04 0.21 ± 0.03 0.19 ± 0.05 0.21 ± 0.03 0.569 ns ns ns ns ns ns
RVFWTd (mm) 0.61 ± 0.05 0.78 ± 0.04 0.95 ± 0.20 0.88 ± 0.33 <0.001 <0.001 <0.001 0.002 0.007 0.305 1.000
TAPSE (mm) 1.11 ± 0.64 1.02 ± 0.13 0.72 ± 0.16 0.71 ± 0.14 <0.001 1.000 0.010 0.129 <0.001 <0.001 1.000
PAAT/CL (mm/s) 0.23 ± 0.15 0.21 ± 0.05 0.14 ± 0.06 0.12 ± 0.04 <0.001 1.000 0.007 0.017 0.127 0.086 1.000
LV systolic pressure (mmHg) 90.09 ± 15.90 80.50 ± 3.00 46.94 ± 14.65 43.00 ± 9.56 <0.001 1.000 <0.001 0.004 0.012 0.040 1.000
LV diastolic pressure (mmHg) 9.00 ± 4.86 7.50 ± 2.08 6.94 ± 4.02 3.50 ± 1.91 0.073 ns ns ns ns ns ns
RV systolic pressure (mmHg) 20.20 ± 6.60 28.50 ± 5.20 45.10 ± 12.83 49.67 ± 19.91 <0.001 <0.001 <0.001 0.006 0.001 0.011 1.000
RV diastolic pressure (mmHg) 4.40 ± 2.55 8.00 ± 2.00 6.00 ± 3.89 6.67 ± 4.68 0.012 0.008 0.748 1.000 0.161 0.508 1.000

LV: left ventricle; LVFWTd: end-diastolic left ventricular free wall thickness; PAAT/CL: pulmonary artery acceleration time normalized to cycle length; PAH: pulmonary arterial hypertension; RV: right ventricle; RVFWTd: end-diastolic right ventricular free wall thickness; TAPSE: tricuspid annular plane systolic excursion

Statistically significant p-values are given in italics